Dermatology Times Newsletter

To view this email as a web page, click here.

Clinical Considerations for Derm NPs and PAs

Don’t be afraid to treat acne in patients who are pregnant. This is the take-home message in our first article this month. To further the acne discussion, Dr. Harper describes the safety of anti-androgenic therapies for the treatment of acne in female patients. Finally, there are so many systemic therapeutic options for the treatment of plaque psoriasis, ranging from oral methotrexate to small molecules and biologic agents. How do you determine a starting point? Read on for practical insights into treating your patients with acne and psoriasis.
— Joe Gorelick, MSN, FNP-C, DERM Founder & Chairman, California Skin Institute

CLINICAL CONSIDERATIONS

Helpful tips to treat acne in pregnancy

Dr. Jonette Keri offers recommendations for treatment, identifies first-line prescription topical agents and recommends the use of an appropriate oral antibiotic as necessary. Which oral antibiotic do you prescribe for your pregnant acne patients? Treating acne in pregnancy requires familiarity with FDA medication categories, she notes, as well as having a thorough discussions with patients. Learn more helpful tips for safe and effective management of acne during pregnancy.

Register for DERM2018 to advance your dermatology knowledge and skills.

Spironolactone prescriptions for acne rise

Prescription data suggests a nearly four-fold increase in the number of spironolactone courses among dermatology prescribers from 2004 to 2013. The reason for this increase is multifactorial and is clearly driven by an attempt to mitigate antibiotic resistance and the effect of antibiotics on the gut. Dr. Julie C. Harper describes the safety of anti-androgenic therapies for the treatment of acne in female patients, noting that while headed in the right direction, more physicians need to feel comfortable.

A review of adverse events in plaque psoriasis

As the list of treatments for plaque psoriasis grows, so does the list of adverse events that are associated with biologic treatment. Our challenge is to maximize the efficacy for our patients so they can have the best possible disease control while minimizing the risk of adverse events. A thorough patient history and laboratory evaluation, combined with an assessment of the patient's lifestyle will help guide us to the most appropriate therapeutic agent. In this article Dr. Anthony Fernandez provides a very helpful review of class-based, treatment-related adverse events for plaques psoriasis.

JOB OPPORTUNITIES

AZ - Integrated Dermatology

CO - Dermatology Specialists of Boulder

CO - Leavitt Management Group

CT - Integrated Dermatology

FL - Integrated Dermatology

FL - Leavitt Management Group

GA - Leavitt Management Group

IL - Integrated Dermatology

MA - Integrated Dermatology

MD - Integrated Dermatology

MI - Leavitt Management Group

National - Integrated Dermatology

NC - Integrated Dermatology

NJ - Integrated Dermatology

NY - Integrated Dermatology

OR - Cynthia Dreyer MD

PA - Leavitt Management Group

PA - Integrated Dermatology

RI - Leavitt Management Group

TN - Integrated Dermatology

TX - Company Confidential

VA - Integrated Dermatology

WA - Integrated Dermatology

WY - Leavitt Management Group

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.

CONNECT